1. Home
  2. ATYR vs SPIR Comparison

ATYR vs SPIR Comparison

Compare ATYR & SPIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • SPIR
  • Stock Information
  • Founded
  • ATYR 2005
  • SPIR 2012
  • Country
  • ATYR United States
  • SPIR United States
  • Employees
  • ATYR N/A
  • SPIR N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • SPIR Telecommunications Equipment
  • Sector
  • ATYR Health Care
  • SPIR Consumer Discretionary
  • Exchange
  • ATYR Nasdaq
  • SPIR Nasdaq
  • Market Cap
  • ATYR 290.6M
  • SPIR 251.8M
  • IPO Year
  • ATYR 2015
  • SPIR N/A
  • Fundamental
  • Price
  • ATYR $3.30
  • SPIR $9.82
  • Analyst Decision
  • ATYR Strong Buy
  • SPIR Strong Buy
  • Analyst Count
  • ATYR 6
  • SPIR 5
  • Target Price
  • ATYR $18.60
  • SPIR $16.25
  • AVG Volume (30 Days)
  • ATYR 1.1M
  • SPIR 563.1K
  • Earning Date
  • ATYR 05-07-2025
  • SPIR 05-19-2025
  • Dividend Yield
  • ATYR N/A
  • SPIR N/A
  • EPS Growth
  • ATYR N/A
  • SPIR N/A
  • EPS
  • ATYR N/A
  • SPIR N/A
  • Revenue
  • ATYR N/A
  • SPIR $110,451,000.00
  • Revenue This Year
  • ATYR $551.06
  • SPIR $2.24
  • Revenue Next Year
  • ATYR $2,144.84
  • SPIR $25.73
  • P/E Ratio
  • ATYR N/A
  • SPIR N/A
  • Revenue Growth
  • ATYR N/A
  • SPIR 13.15
  • 52 Week Low
  • ATYR $1.42
  • SPIR $6.26
  • 52 Week High
  • ATYR $4.66
  • SPIR $21.43
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 52.29
  • SPIR 54.08
  • Support Level
  • ATYR $3.06
  • SPIR $9.04
  • Resistance Level
  • ATYR $3.45
  • SPIR $10.13
  • Average True Range (ATR)
  • ATYR 0.24
  • SPIR 0.69
  • MACD
  • ATYR 0.01
  • SPIR 0.06
  • Stochastic Oscillator
  • ATYR 52.46
  • SPIR 53.16

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About SPIR Spire Global Inc.

Spire Global Inc is a provider of space-based data, analytics, and Space Services, offering datasets and powerful insights about Earth from the ultimate vantage point of space so that organizations can make decisions with confidence, accuracy, and speed. It generates revenue from four solutions: Maritime, Aviation, Weather, and Space Services. It offers the following three data solutions to customers; Maritime-precise space-based data used for accurate ship monitoring, ship safety, and route optimization, Aviation-precise space-based data used for accurate aircraft monitoring, aircraft safety, and route optimization, and Weather-precise space-based data used for accurate weather forecasting.

Share on Social Networks: